| Your Current Location : Fund Card : Portfolio Classification |
 |
|
|
| |
| Tata Nifty MidSmall Healthcare Index Fund (G) Direct |
| [Equity: Index] |
|
| |
|
|
| Instruments Breakdown |
| Instruments |
Composition |
| Current Asset |
-0.13 |
| Equity |
100.06 |
| Trep |
0.07 |
|
| |
| Concentration Analysis |
| Top 5 Holdings |
38.81% |
| Top 10 Holdings |
60.20% |
| Top 25 Holdings |
94.15% |
|
|
|
| |
| Sector Analysis |
| Sector/Ratings |
Net Asset(%) |
| Pharma & Biotech |
77.53 |
| Healthcare |
22.53 |
| Cash |
-0.06 |
|
|
|
|
|
| Portfolio Metrics |
|
| PB Ratio |
0.00 |
| PE Ratio |
43.39 |
|
| |
| Top 25 Holdings |
|
|
| Holdings |
Net Asset(%) |
| Laurus Labs Limited |
9.36 |
| Lupin Limited |
9.30 |
| Fortis Health Care Ltd |
7.90 |
| Aurobindo Pharma Limited |
6.99 |
| Glenmark Pharmaceuticals Limited |
5.26 |
| Alkem Laboratories Limited |
5.17 |
| Biocon Limited |
4.73 |
| Mankind Pharma Limited |
4.56 |
| IPCA Laboratories Limited |
3.74 |
| Krishna Inst of Medical Sciences Ltd. |
3.19 |
| Gland Pharma Limited |
3.15 |
| Aster DM Healthcare Limited |
3.15 |
| J B Chemicals and Pharma Ltd |
2.98 |
| Sai Life Sciences Limited |
2.69 |
| Wockhardt Limited |
2.54 |
| Neuland Laboratories Limited |
2.54 |
| Ajanta Pharma Limited |
2.28 |
| Narayana Hrudalaya Ltd |
2.16 |
| Abbott India Limited |
2.10 |
| Dr Lal Path Labs Ltd |
2.03 |
| Granules India Limited |
1.87 |
| EQ- GLOBAL HEALTH LTD. |
1.76 |
| Piramal Pharma Limited |
1.65 |
| GLAXO SMITHKLINE PHARMA |
1.61 |
| One Source Specialty Pharma Ltd |
1.44 |
|
|
|
| |
|
| |
| Sector Analysis Graphical Mode |
|
| |
|
|
| |
|
 |
| |
|
|
|